Willingness to take Antiretroviral Drugs in a high HIV prevalence Setting: the case of Adults living in Chawama, Lusaka, Zambia
Keywords:
Willingness, Antiretroviral Drugs, HIV
Abstract
The willingness to take antiretroviral drugs (ARVs) has been found to be associated with several factors. We investigated the level of willingness to take antiretroviral drugs and factors likely to be associated with willingness among adults living in Chawama township. This was a cross-sectional study of 409 adult respondents aged 18 years and above, recruited by a simple random sampling method. A structured questionnaire was used to collect socio- demographic data and other factors likely to influence willingness. Determinants of willingness and association between variables of interest were examined using multivariate analysis. Results revealed that about 52.8% of females and 46.9% of males participated in the study. The mean age of participants was 31years (SD±11.60). The response rate was 99%. A high level of willingness was observed, with more than 50% of participants willing to take ARVs if they were found legible for ART. Some of the key factors that were found significantly associated with willingness were the aspect of being male or female, with females being more likely to be willing than males, the perceived effectiveness of ARVs, the need for consent to begin ARV treatment with females being more likely to needing consent than men, and fear of discrimination. There is a high willingness to take antiretroviral drugs among community members suggesting a high potential to influence individual acceptability and general uptake of ARVs. Furthermore, stigmatizing attitudes and socio-cultural influences towards people taking ARVs persist and interventions to reduce these influences are needed.References
1. Badri et al (2004). An assessment of the revised World Health Organization scaling-up guidelines AIDS Journal: Vol 18(8) 1159-1168.
2. Baylor International Pediatric AIDS Initiative (BIPAI) (2006). HIV Curriculum for the Health Professional. Baylor College of Medicine
3. Central Statistical Office (CSO) (2007).Zambia Demographic Health Survey- Preliminary Report. Government Printers.
4. Central Statistical Office (CSO) (2003). Zambia Demographic Health Survey. Government Printers.
5. Central Statistical Office (CSO) (1999). Zambia Sexual Behavior Survey 1998 Ministry of Health, Measure Evaluation. Lusaka, Zambia. Government Pri
6. Chitambo (2007) Living with Hope - African Churches and HIV/AIDS1.World Council of Churches, Geneva2. Switzerland
7. Dilger H etal (2009). Prolonging Life, Challenging Religion. Justo Mwale College, Lusaka Zambia
8. Gomani P et al (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and Tuberculosis in Rural Malawi is low and associated with Cost of Transport. The International journal of Tuberculosis and Lung Diseases, 9(3) 238-47 PUBMED
9. The British Columbia Centre for Excellence in HIV/ AIDS (2004), 15th International Conference on AIDS. Bangkok, Vancouver, Canada
10. Lusaka City Council (LCC) (2007). A Report on the Status of Unplanned Settlements in Lusaka. Government Printers.
11. Mathew P Fox, A Mazimba etal (2010). Barriers To Initiation Of Antiretroviral Treatment In Rural And Urban Areas Of Zambia: A Cross-Sectional Study Of Cost, Stigma, and Perceptions About ART. Journal Of The International AIDS Society, (2010).
12. MOH (2008). Multi-sectoral AIDS Response Monitoring and Evaluation Biennial Report 2006-2007. Government Printers.
13. MOH b (2008). Management of Adult HIV with Antiretroviral Therapy. A Reference Manual for Health Workers. Government Printers.
14. MOH (2007). ARVs, HIV and VCT. Annual Health Statistical Bulletin 2006, November, pp.24 Government Printers.
15. MOH b (2007). 2007 Antiretroviral Therapy Protocols. Pocket Guide Government Printers.
16. MOH (2006). Scale – UP Plan. HIV Care and Antiretroviral Therapy Services 2006 – 2008. Government Printers.
17. MOH (2005). Towards Attainment of the Millennium Development Goals, and National Health Priorities, HIV/AIDS and STI. National Health Strategic Plan 2006- 2010, November. Government Printers.
18. MOH b (2005). National HIV/AIDS/STI/TB Policy. Lusaka Zambia, Government Printers.
19. Montgomery ET et al (2004). Factors influencing VCT Uptake & ART acceptance for Zimbabwean Antenatal Women. International Conference on AIDS Bangkok, Thailand abstract no. TuPeD5182. UZ-UCSF, Harare, Zimbabwe.
20. National Aids Council and MOH (2010). Monitoring the Declaration of Commitment on HIV/AIDS and the Universal Access. Zambia Country Report Lusaka, Government printers.
21. National Aids Council (2004). Joint Review of the National HIV/AIDS/STI/TB Intervention Strategic Plan (2002-2005) and Operations of the National AIDS Council. Lusaka, Government printers.
22. National AIDS Council (2008). HIV and AIDS in Zambia
a. http://www.avert.org/aids-zambia.htm
23. Padarath et al (2006). Community Participation in HIV and ARV services Journal of South African Health Review pp: 95-104.
24. Rutaremwa G (2004). Individual attitudes, perceptions and beliefs toward HIV/AIDS care, prevention and control in Uganda: cross-sectional evidence from Uganda. International Conference on AIDS (15th: 2004: Bangkok, Thailand). Abstract no. TuPeD5189. Makerere University, Kampala, Uganda.
25. Schumaker L and Bond V (2008). Antiretroviral therapy in Zambia: Colors, 'Spoiling, 'Talk' and the meaning of Antiretrovirals. An International Journal of Social Science and Medicine. Elsevier Ltd .
26. Siulanda N (2007). HIV/AIDS- In search of a cure- ARVs Vs Herbal Remedies. Health and Wellness. Panorama Journal.
27. Tsiko S (2004) ARVs Bring New Hope. The Journal of Health Systems Trust http://www.hst.org.za/news/20040417.
28. UNAIDS (1998). Gender and HIV/AIDS http://whqlibdoc.who.int/unaids/1998/gender_HIV_eng. pdf.
29. WHO (2008). Statistics http://www.who.int/countries/zmb/en/
30. WHO/AFRO (2007). WHO Statement on treatment of HIV/AIDS. PRESS RELEASE.
31. WHO (2006). Adherence Research. World Health Organization Collaborating Center on Pharmaceutical Policy .
32. WHO (2003). Fact sheet 134. Traditional Medicine.
33. WHO/AFRO (2001). Traditional Medicines Show 'Encouraging Results' In Management Of HIV/AIDS. PRESS RELEASE WHO STATE
34. Willard S & Angelino A (2008).The Need for Socio- cultural Awareness to Maximize Treatment Acceptance and Adherence in Individuals Initiating HIV Therapy. Journal of the international Association of physicians in AIDS cure
35. Shannon K, Bright V, et al (2004) Uptake and acceptance of antiretroviral medications among female sex workers. Vancouver's downtown eastside.
36. UNAIDS (2008). Report on the global AIDS Epidemic. UNAIDS Geneva
37. UNAIDS (1998). Guidance Modules On Antiretroviral Treatments
38. Zuumond M (2008). CAFOD-Adherence to ARVs- Challenges and Success A Consultation with CAFOD Partners and Members of the Catholic HIV/AIDS Network (CHAN). Research Report
2. Baylor International Pediatric AIDS Initiative (BIPAI) (2006). HIV Curriculum for the Health Professional. Baylor College of Medicine
3. Central Statistical Office (CSO) (2007).Zambia Demographic Health Survey- Preliminary Report. Government Printers.
4. Central Statistical Office (CSO) (2003). Zambia Demographic Health Survey. Government Printers.
5. Central Statistical Office (CSO) (1999). Zambia Sexual Behavior Survey 1998 Ministry of Health, Measure Evaluation. Lusaka, Zambia. Government Pri
6. Chitambo (2007) Living with Hope - African Churches and HIV/AIDS1.World Council of Churches, Geneva2. Switzerland
7. Dilger H etal (2009). Prolonging Life, Challenging Religion. Justo Mwale College, Lusaka Zambia
8. Gomani P et al (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and Tuberculosis in Rural Malawi is low and associated with Cost of Transport. The International journal of Tuberculosis and Lung Diseases, 9(3) 238-47 PUBMED
9. The British Columbia Centre for Excellence in HIV/ AIDS (2004), 15th International Conference on AIDS. Bangkok, Vancouver, Canada
10. Lusaka City Council (LCC) (2007). A Report on the Status of Unplanned Settlements in Lusaka. Government Printers.
11. Mathew P Fox, A Mazimba etal (2010). Barriers To Initiation Of Antiretroviral Treatment In Rural And Urban Areas Of Zambia: A Cross-Sectional Study Of Cost, Stigma, and Perceptions About ART. Journal Of The International AIDS Society, (2010).
12. MOH (2008). Multi-sectoral AIDS Response Monitoring and Evaluation Biennial Report 2006-2007. Government Printers.
13. MOH b (2008). Management of Adult HIV with Antiretroviral Therapy. A Reference Manual for Health Workers. Government Printers.
14. MOH (2007). ARVs, HIV and VCT. Annual Health Statistical Bulletin 2006, November, pp.24 Government Printers.
15. MOH b (2007). 2007 Antiretroviral Therapy Protocols. Pocket Guide Government Printers.
16. MOH (2006). Scale – UP Plan. HIV Care and Antiretroviral Therapy Services 2006 – 2008. Government Printers.
17. MOH (2005). Towards Attainment of the Millennium Development Goals, and National Health Priorities, HIV/AIDS and STI. National Health Strategic Plan 2006- 2010, November. Government Printers.
18. MOH b (2005). National HIV/AIDS/STI/TB Policy. Lusaka Zambia, Government Printers.
19. Montgomery ET et al (2004). Factors influencing VCT Uptake & ART acceptance for Zimbabwean Antenatal Women. International Conference on AIDS Bangkok, Thailand abstract no. TuPeD5182. UZ-UCSF, Harare, Zimbabwe.
20. National Aids Council and MOH (2010). Monitoring the Declaration of Commitment on HIV/AIDS and the Universal Access. Zambia Country Report Lusaka, Government printers.
21. National Aids Council (2004). Joint Review of the National HIV/AIDS/STI/TB Intervention Strategic Plan (2002-2005) and Operations of the National AIDS Council. Lusaka, Government printers.
22. National AIDS Council (2008). HIV and AIDS in Zambia
a. http://www.avert.org/aids-zambia.htm
23. Padarath et al (2006). Community Participation in HIV and ARV services Journal of South African Health Review pp: 95-104.
24. Rutaremwa G (2004). Individual attitudes, perceptions and beliefs toward HIV/AIDS care, prevention and control in Uganda: cross-sectional evidence from Uganda. International Conference on AIDS (15th: 2004: Bangkok, Thailand). Abstract no. TuPeD5189. Makerere University, Kampala, Uganda.
25. Schumaker L and Bond V (2008). Antiretroviral therapy in Zambia: Colors, 'Spoiling, 'Talk' and the meaning of Antiretrovirals. An International Journal of Social Science and Medicine. Elsevier Ltd .
26. Siulanda N (2007). HIV/AIDS- In search of a cure- ARVs Vs Herbal Remedies. Health and Wellness. Panorama Journal.
27. Tsiko S (2004) ARVs Bring New Hope. The Journal of Health Systems Trust http://www.hst.org.za/news/20040417.
28. UNAIDS (1998). Gender and HIV/AIDS http://whqlibdoc.who.int/unaids/1998/gender_HIV_eng. pdf.
29. WHO (2008). Statistics http://www.who.int/countries/zmb/en/
30. WHO/AFRO (2007). WHO Statement on treatment of HIV/AIDS. PRESS RELEASE.
31. WHO (2006). Adherence Research. World Health Organization Collaborating Center on Pharmaceutical Policy .
32. WHO (2003). Fact sheet 134. Traditional Medicine.
33. WHO/AFRO (2001). Traditional Medicines Show 'Encouraging Results' In Management Of HIV/AIDS. PRESS RELEASE WHO STATE
34. Willard S & Angelino A (2008).The Need for Socio- cultural Awareness to Maximize Treatment Acceptance and Adherence in Individuals Initiating HIV Therapy. Journal of the international Association of physicians in AIDS cure
35. Shannon K, Bright V, et al (2004) Uptake and acceptance of antiretroviral medications among female sex workers. Vancouver's downtown eastside.
36. UNAIDS (2008). Report on the global AIDS Epidemic. UNAIDS Geneva
37. UNAIDS (1998). Guidance Modules On Antiretroviral Treatments
38. Zuumond M (2008). CAFOD-Adherence to ARVs- Challenges and Success A Consultation with CAFOD Partners and Members of the Catholic HIV/AIDS Network (CHAN). Research Report
Published
2022-09-08
How to Cite
1.
Munthali S, Michelo C. Willingness to take Antiretroviral Drugs in a high HIV prevalence Setting: the case of Adults living in Chawama, Lusaka, Zambia. Journal of Agricultural and Biomedical Sciences [Internet]. 8Sep.2022 [cited 23Dec.2024];6(1). Available from: https://ide.unza.zm/index.php/JABS/article/view/857
Section
Biomedical Sciences
Copyright: ©️ JABS. Articles in this journal are distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.